208 related articles for article (PubMed ID: 33121230)
1. An Overview of Genetic Information of Latent Mycobacterium tuberculosis.
Hamidieh F; Farnia P; Nowroozi J; Farnia P; Velayati AA
Tuberc Respir Dis (Seoul); 2021 Jan; 84(1):1-12. PubMed ID: 33121230
[TBL] [Abstract][Full Text] [Related]
2. Persistent and dormant tubercle bacilli and latent tuberculosis.
Zhang Y
Front Biosci; 2004 May; 9():1136-56. PubMed ID: 14977534
[TBL] [Abstract][Full Text] [Related]
3.
Salina EG; Makarov V
Microorganisms; 2022 Nov; 10(12):. PubMed ID: 36557586
[TBL] [Abstract][Full Text] [Related]
4. A mathematical representation of the development of Mycobacterium tuberculosis active, latent and dormant stages.
Magombedze G; Mulder N
J Theor Biol; 2012 Jan; 292():44-59. PubMed ID: 21968442
[TBL] [Abstract][Full Text] [Related]
5. Dormant non-culturable Mycobacterium tuberculosis retains stable low-abundant mRNA.
Ignatov DV; Salina EG; Fursov MV; Skvortsov TA; Azhikina TL; Kaprelyants AS
BMC Genomics; 2015 Nov; 16():954. PubMed ID: 26573524
[TBL] [Abstract][Full Text] [Related]
6. Drug targets in dormant Mycobacterium tuberculosis: can the conquest against tuberculosis become a reality?
Gupta VK; Kumar MM; Singh D; Bisht D; Sharma S
Infect Dis (Lond); 2018 Feb; 50(2):81-94. PubMed ID: 28933243
[TBL] [Abstract][Full Text] [Related]
7. New Approaches and Therapeutic Options for Mycobacterium tuberculosis in a Dormant State.
Caño-Muñiz S; Anthony R; Niemann S; Alffenaar JC
Clin Microbiol Rev; 2018 Jan; 31(1):. PubMed ID: 29187395
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic luciferase reporter phage assay for active and non-replicating persistors to detect tubercle bacilli from sputum samples.
Dusthackeer VN; Balaji S; Gomathi NS; Selvakumar N; Kumar V
Clin Microbiol Infect; 2012 May; 18(5):492-6. PubMed ID: 21848970
[TBL] [Abstract][Full Text] [Related]
9. Dormancy of Mycobacterium tuberculosis and latency of disease.
Wayne LG
Eur J Clin Microbiol Infect Dis; 1994 Nov; 13(11):908-14. PubMed ID: 7698116
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a guinea pig model of latent tuberculosis with GFP-introduced Mycobacterium tuberculosis.
Sugawara I; Udagawa T; Aoki T; Mizuno S
Tohoku J Exp Med; 2009 Nov; 219(3):257-62. PubMed ID: 19851055
[TBL] [Abstract][Full Text] [Related]
11. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
12. On the nature of Mycobacterium tuberculosis-latent bacilli.
Cardona PJ; Ruiz-Manzano J
Eur Respir J; 2004 Dec; 24(6):1044-51. PubMed ID: 15572551
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of dormant "non-culturable" Mycobacterium tuberculosis developed in vitro after injection in mice: both the dormancy depth and host genetics influence the outcome.
Shleeva M; Kondratieva T; Rubakova E; Vostroknutova G; Kaprelyants A; Apt A
Microb Pathog; 2015 Jan; 78():63-6. PubMed ID: 25434928
[TBL] [Abstract][Full Text] [Related]
14. Populations of latent Mycobacterium tuberculosis lack a cell wall: Isolation, visualization, and whole-genome characterization.
Velayati AA; Abeel T; Shea T; Konstantinovich Zhavnerko G; Birren B; Cassell GH; Earl AM; Hoffner S; Farnia P
Int J Mycobacteriol; 2016 Mar; 5(1):66-73. PubMed ID: 26927992
[TBL] [Abstract][Full Text] [Related]
15. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
16. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection.
Tufariello JM; Chan J; Flynn JL
Lancet Infect Dis; 2003 Sep; 3(9):578-90. PubMed ID: 12954564
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium aurum is Unable to Survive Mycobacterium tuberculosis Latency Associated Stress Conditions: Implications as Non-suitable Model Organism.
Sood S; Yadav A; Shrivastava R
Indian J Microbiol; 2016 Jun; 56(2):198-204. PubMed ID: 27570312
[TBL] [Abstract][Full Text] [Related]
18. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.
Singh S; Saraav I; Sharma S
Vaccine; 2014 Feb; 32(6):712-6. PubMed ID: 24300592
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
